Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

07.08.25 15:30 Uhr

Werte in diesem Artikel
Aktien

65,50 EUR -0,50 EUR -0,76%

Kenvue (KVUE) reported $3.84 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 4%. EPS of $0.29 for the same period compares to $0.32 a year ago.The reported revenue represents a surprise of -0.51% over the Zacks Consensus Estimate of $3.86 billion. With the consensus EPS estimate being $0.28, the EPS surprise was +3.57%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Kenvue performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- Self Care: $1.56 billion versus the two-analyst average estimate of $1.6 billion. The reported number represents a year-over-year change of -4.9%.Net Sales- Essential Health: $1.23 billion versus $1.23 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.9% change.Net Sales- Skin Health and Beauty: $1.06 billion versus the two-analyst average estimate of $1.04 billion. The reported number represents a year-over-year change of -4%.View all Key Company Metrics for Kenvue here>>>Shares of Kenvue have returned +3.3% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kenvue Inc. (KVUE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Kenvue

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Kenvue

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Kenvue

Wer­bung